Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): Specific up-regulation by tumour necrosis factor-alpha (TNF-α) in synovial fluid

Clinical and Experimental Immunology

Volumn 117, Issue 1, 1999, Pages 171-176

  Bottomley, M J ^a   Webb, N J A ^a   Watson, C J ^a   Holt, P J L ^a   Freemont, A J ^a   Brenchley, P E C ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MRI   (United Kingdom)

Author keywords

Cytokines; Monocytes; Rheumatoid arthritis; VEGF

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IMMUNOREGULATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SECRETION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; ENDOTHELIAL GROWTH FACTORS; HUMANS; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOKINES; SYNOVIAL FLUID; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033043161     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00949.x     Document Type: Article

References (47)

1. Harris ED. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Eng J Med 1990; 322:1277-88.
2. Yanni G, Whelan A, Feighery C, Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis 1994; 54:39-44.
3. Janossy G, Panayi G, Duke O et al. Rheumatoid arthritis: A disease of T lymphocyte macrophage immunoregulation. Lancet 1981; 2:834-42.
4. Allen CA, Highton J, Palmer DG. Increased expression of p150.95 and CR3 leukocyte adhesion molecules by mononucleur phagocytes in rheumatoid synovial membranes. Arthritis Rheum 1989; 32:947-54.
5. Kirkham BW, Navaro FJ, Corkill MM et al. Immunohistochemical localisation of interleukin 1 in rheumatoid and osteoarthritis synovial membrane. J Rheumatol 1989; 28 (Suppl.2):47 (Abstr. 82).
6. Chu CQ, Field M, Feldman M, Maini RN. Localisation of tumour necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991; 34:1125-32.
7. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterisation of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 1989; 86:7311-5.
8. Senger DR, Galli SS, Dvorak AM et al. Tumour cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219:983-5.
9. Conn G, Bayne ML, Soderman DD et al. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acid Sci USA 1990; 87:2628-32.
10. Olofsson B, Pajusola K, Kapainen A et al. Vascular endothelial growth factor B, a novel growth for endothelial cells. Proc Natl Acad Sci USA 1996; 93:2576-81.
11. Joukov V, Pajusola K, Kapainen A et al. A novel vascular endothelial growth factor, VEGF-C, in a ligand for Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15:290-8.
12. Lee J, Gray A, Yuan J et al. Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci USA 1996; 93:1988-92.
13. de Vries C, Escobedo JA, Ueno H et al. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255:989-91.
14. Terman BI, Dougher-Vermazen M, Carrion ME et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992; 187:1579-86.
15. Shen H, Clauus M, Ryan J et al. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 1993; 81:2767-73.
16. Li J, Perrella MA, Tsai JC et al. Induction or vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells. J Biol Chem 1995; 270:308-12.
17. Brogi E, Wu TG, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1990; 90:649-52.
18. Pertovaara L, Kaipainen A, Mustonen T et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 1994; 269:6271-4.
19. Pepper MS, Vassalli JD, Orci L, Montesano R. Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis. Exp Cell Res 1993; 204:356-63.
20. Stavri GT, Zachary IC, Baskerville PA et al. Basic fibroblastic growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: Synergistic interaction with hypoxia. Circulation 1995; 92:11-14.
21. Goldman CK, Kim J, Wong WL et al. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: A model of glioblastoma multiforme pathophysiology. Mol Biol Cell 1993; 4:121-33.
22. Detmar M, Yeo KT, Nagy JA et al. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 1995; 105:44-50.
23. Williams B, Baker AQ, Gallacher B, Lodwick D. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 1995; 25:913-7.
24. Fava RA, Olsen NJ, Spencer-Green G et al. Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994; 180:341-6.
25. Bottomley MJ, Holt PLJ, Watson CJ et al. Vascular endothelial growth factor mediates synovial inflammation. Arthritis Rheum 1996; 39:9, S131.
26. Koch AE, Harlow LA, Haines GK et al. Vascular endothelial growth factor - A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994; 152:4149-56.
27. Nagashima M, Yoshino S, Ishiwata T, Asano G. The role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 1995; 22:1624-30.
28. Freemont AJ, Denton J. Atlas of Synovial Fluid Cytopathology. Vol 18. Higham, USA: Kluwer, 1991.
29. Boyum A. Separation of white blood cells. Nature 1964; 204:793-4.
30. Webb NJA, Bottomley MJ, Watson CJ, Brenchley PEC. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: Implications for measurement of circulating VEGF levels in clinical science. Clin Sci 1998; 94:395-405.
31. Iijima K, Yoshikawa N, Nakamura H. Activation-induced expression of vascular permeability factor by human peripheral T cells: A nonradioisotope semiquantitative reverse transcription-polymerase chain reaction assay. J Immunol Methods 1996; 196:199-206.
32. Freeman MR, Schneck FX, Gagnon MI et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis. Cancer Res 1995; 55:4140-5.
33. Cooper JC, Sharkey AM, McLaren J et al. Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunohistochemistry. J Reprod Fertil 1995; 105:205-13.
34. Brogi E, Tiangen W, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994; 90:649-52.
35. Koochekpour S, Merzak A, Pilkington GJ. Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro. Cancer Lett 1996; 102:209-15.
36. Mandriota SJ, Menoud PA, Pepper MS. Transforming growth factor beta I down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells. J Biol Chem 1996; 271:115000-5.
37. Liebovich SJ, Polverini PJ, Shepard HM et al. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α. Nature 1987; 329:630-2.
38. Ryuto M, Ono M, Izumi H et al. Induction of vascular endothelial growth factor by tumour necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem 1996; 271:28220-8.
39. Elliott MJ, Maini RN, Feldmann M et al. Randomised double-blind comparison of monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 1994; 344:1105-10.
40. Elliott MJ, Maini RN, Feldmann M et al. Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet 1994; 344:1125-7.
41. Sunderkottcr C, Steinbrink K, Goebeler M et al. Macrophages and angiogenesis. J Leuk Biol 1994; 55:410-22.
42. Hart PH, Vitti GF, Burgess DR et al. Potential anti-inflammatory effects of interleukin-4: Suppression of human monocyte tumour necrosis factor α, interleukin-1 and prostaglandin F2. Proc Natl Acad Sci USA 1989; 86:3803-7.
43. Lacraz S, Nicod I, Galve-de Rochemonteux B et al. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest 1992; 90:382-6.
44. Katsikis P, Chu CQ, Brennan FM et al. Immunoregulatory role of interleukin 10 (IL-10) in rheumatoid arthritis. J Exp Med 1994; 179:1517-27.
45. Llorente L, Richaud-Patin Y, Fior R et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogrens syndrome, and systemic lupus erythematosus. Arthritis Rheum 1994; 37:1647-55.
46. Hopkins SJ, Meager A. Cytokines in synovial fluid II. The presence of tumour necrosis factor and interferon. Clin Exp Immunol 1988; 73:88-92.
47. Di Giovine FS, Nuki G, Duff GW. Tumour necrosis factor in synovial exudates. Ann Rheum Dis 1998; 47:768-72.